Diagnosis and antifungal prophylaxis for covid-19 associated pulmonary aspergillosis

HIGHLIGHTS

  • who: Armani M. Hawes and Nitipong Permpalung from the Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA have published the research: Diagnosis and Antifungal Prophylaxis for COVID-19 Associated Pulmonary Aspergillosis, in the Journal: Antibiotics 2022, 11, x FOR PEER REVIEW of /2022/
  • what: The aim of this work was to describe the current diagnostic landscape of CAPA and review the existing literature on prophylaxis.

SUMMARY

    Intensive care unit (ICU) cohort studies have reported the incidence of CAPA to range from 5% to 30% in patients with . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?